Should You Invest in MS Stock Following Impressive 1H26 Results?

Morgan Stanley MS delivered a strong first half of 2026, with net revenues rising 21% year over year to $41.93 billion and net income jumping 42% to $11.15 billion. Earnings per share increased 46% to $6.90, while the return on tangible common equity (ROTCE) improved to 26.8% from 20.6% in the prior-year period.

The Institutional Securities (IS) segment was the major growth driver, supported by robust investment banking (IB) and trading activity. IB revenues rose 47% year over year, aided by stronger M&A advisory and underwriting volumes, while trading revenues increased 36% on higher client activity. The momentum was particularly evident in the second quarter of this year, when IS segment revenues jumped to a record $11 billion.

The Wealth Management (WM) segment also delivered solid growth in the six months ended June 30, 2026, supported by higher asset levels, fee-based inflows, lending activity and client engagement. Second-quarter revenues reached a record $8.9 billion, while the business attracted $148 billion of net new assets. Investment Management (IM) also benefited from higher assets under management (AUM) and positive flows.

Overall, Morgan Stanley’s improving efficiency, strong asset gathering and solid capital position drove its impressive first-half results. Supported by this robust performance, along with improving investor sentiment, resilient U.S. consumer spending and continued heightened market activity, MS shares have gained 22.1% year to date, outperforming the S&P 500 Index’s 11.5% growth and the industry’s 11% rise.

If we compare MS’ price performance with two of its closest peers, JPMorgan JPM and Goldman Sachs GS, it appears that MS has outperformed both JPMorgan and Goldman Sachs. So far this year, shares of JPMorgan have gained 10.7% and Goldman Sachs stock has rallied 20.5%.

YTD Price Performance

Image Source: Zacks Investment Research

Given the impressive price performance, investors might be tempted to invest in the MS stock now. But before making any investment decision, investors should assess whether there is further upside left in the stock despite risks from market volatility. In order to understand this, let us dig deep into the company’s fundamental strengths and growth prospects.

Key Positives of Morgan Stanley

Improving Diversification: Morgan Stanley has continuously been trying to reduce its reliance on capital markets, which it has been achieving by expanding wealth and asset management. Also, it has been using acquisitions (Eaton Vance, E*Trade Financial, Shareworks and EquityZen) to broaden its mix and have a more balanced revenue stream across market cycles. The wealth and asset management businesses continue to broaden the company’s revenue base and deepen client relationships.

Both businesses’ aggregate contribution to total net revenues jumped to almost 54% in 2025 from 26% in 2010. The WM segment’s total client assets witnessed a five-year (2020-2025) compound annual growth rate (CAGR) of 13%, while the IM segment’s total AUM saw a CAGR of 19.4%.

As of June 30, 2026, total client assets across both segments were $10 trillion, reaching a milestone. This progress reflects strong momentum across Morgan Stanley’s advisor-led, workplace and self-directed platforms, while highlighting its expanding scale in the retirement savings market. The trend is likely to continue in the near term as the operating environment becomes more favorable.

IB Recovery: After the deal slowdown that weighed on results in 2022 and 2023, Morgan Stanley's IB franchise continues to recover as issuance and strategic activity improve. IB fees rose 35% in 2024 and 23% in 2025 as boardroom confidence improved and issuance reopened. As mentioned above, the upward momentum carried into the first half of 2026.

Looking ahead, the company is well-positioned to benefit from a healthier deal environment, supported by a robust and diversified pipeline across regions and sectors. Momentum is expanding beyond the Americas into Asia and EMEA, while active M&A and IPO markets, together with the company’s strong competitive position, should support further growth as the macroeconomic backdrop evolves.  

Expanding Global Reach: Morgan Stanley’s alliance with Mitsubishi UFJ Financial Group continues to enhance its competitive position in Japan through combined research, sales and execution and coordinated underwriting. This supports a durable franchise in a key market and helps extend coverage across the region.

Asia revenues were $9.42 billion in 2025, up 23% year over year. The momentum carried into the first six months of 2026, aided by stronger client engagement, favorable market conditions and higher prime brokerage activity in the region.

The company's global platform is increasingly relevant as capital markets activity broadens outside the United States and across Japan, India, China, Korea, Taiwan and Hong Kong. Continued investment in regional leadership and collaboration should support wallet share gains across Asia's capital markets and wealth opportunity set.

Robust Balance Sheet Position: As of June 30, 2026, the company had long-term debt of $383.2 billion, with $34.3 billion expected to mature over the next 12 months. The company’s average liquidity resources were $404.1 billion as of the same date.

Given its solid liquidity position and earnings strength, Morgan Stanley has been engaged in efficient capital distribution activities, through which it enhances shareholder value.

Following the clearance of the 2026 stress test, the company increased its quarterly dividend 15% to $1.15 per share. Before this, the company had hiked its quarterly dividend 8% in 2025. Also, its board of directors has reauthorized a multi-year share repurchase program of up to $20 billion, without an expiration date. Management continues to emphasize disciplined capital allocation, with a preference for organic investment, capital returns and selective bolt-on acquisitions only where strategic and cultural fit are strong.

Analyzing Morgan Stanley’s Valuation & Estimates

On a valuation basis, shares of Morgan Stanley appear to be trading at a premium relative to the industry. The company’s forward 12-month price/earnings (P/E) ratio of 16.72 is above the industry average of 13.97.

P/E (F12M)

Image Source: Zacks Investment Research

JPMorgan has a P/E (F12M) ratio of 14.28, and Goldman Sachs has a forward 12-month P/E ratio of 14.89. Thus, Morgan Stanley is overvalued compared with its two closest peers as well.

If we look at Morgan Stanley’s earnings estimate revisions, it appears that analysts are optimistic regarding the company’s growth. Over the past 30 days, the Zacks Consensus Estimate for the company’s 2026 and 2027 earnings has been revised upward. The earnings estimate for 2026 of $12.79 indicates a rise of 25.3% from that reported in the previous year. The 2027 estimate of $13.06 suggests year-over-year growth of 2.1%.

Earnings Estimate Revision

Image Source: Zacks Investment Research

How to Approach Morgan Stanley Stock Now?

Morgan Stanley’s continued efforts to reduce the dependence on volatile capital markets-driven revenues by strengthening its wealth management and investment management businesses will continue to support growth in the long run because these segments generate more stable, recurring fee income.

Its solid balance sheet and strong capital position provide flexibility to invest in growth initiatives, pursue strategic opportunities and return capital to shareholders.

The company’s premium valuation seems justified by its business transformation and strong earnings stability. With multiple growth levers in place, including expansion in fee-based businesses, disciplined cost management and strategic investments, the company appears well-positioned to sustain financial performance and deliver stable revenue growth over the long term, making it an attractive investment option now.

Currently, Morgan Stanley sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research